Journey Medical (DERM) News Today $4.68 +0.03 (+0.65%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short InterestJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 76,700 shares, an increase of 15.9% from the November 15th total of 66,200 shares. Currently, 0.8% of the company's stock are short sold. Based on an average trading volume of 105,000 shares, the short-interest ratio is presently 0.7 days.December 16, 2024 | marketbeat.comFY2024 EPS Forecast for Journey Medical Lowered by AnalystJourney Medical Co. (NASDAQ:DERM - Free Report) - Research analysts at Roth Capital lowered their FY2024 earnings per share estimates for Journey Medical in a note issued to investors on Monday, November 18th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per shNovember 21, 2024 | marketbeat.comJourney Medical management to meet virtually with B. RileyNovember 21, 2024 | markets.businessinsider.comFY2024 EPS Estimates for Journey Medical Raised by B. RileyJourney Medical Co. (NASDAQ:DERM - Free Report) - Stock analysts at B. Riley upped their FY2024 earnings per share (EPS) estimates for shares of Journey Medical in a research report issued to clients and investors on Monday, November 18th. B. Riley analyst K. Patel now forecasts that the companyNovember 20, 2024 | marketbeat.comDespite Journey Medical's Pullback, Insiders Still Gained US$118kNovember 16, 2024 | finance.yahoo.comJourney Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in OctoberJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 60,800 shares, a drop of 20.7% from the October 15th total of 76,700 shares. Based on an average trading volume of 88,700 shares, the short-interest ratio is currently 0.7 days. Approximately 0.6% of the company's shares are sold short.November 15, 2024 | marketbeat.comJourney Medical Reports Q3 2024 Earnings, Eyes Emrosi LaunchNovember 15, 2024 | markets.businessinsider.comLake Street Remains a Buy on Journey Medical Corp (DERM)November 13, 2024 | markets.businessinsider.comJourney Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNovember 12, 2024 | globenewswire.comJourney Medical FY2024 EPS Forecast Boosted by Roth CapitalJourney Medical Co. (NASDAQ:DERM - Free Report) - Investment analysts at Roth Capital boosted their FY2024 earnings per share (EPS) estimates for Journey Medical in a report released on Monday, November 4th. Roth Capital analyst J. Wittes now anticipates that the company will post earnings per shNovember 7, 2024 | marketbeat.comJourney Medical price target raised to $11 from $8.50 at Alliance Global PartnersNovember 6, 2024 | markets.businessinsider.comQ3 EPS Estimates for Journey Medical Decreased by AnalystJourney Medical Co. (NASDAQ:DERM - Free Report) - Investment analysts at Roth Capital dropped their Q3 2025 EPS estimates for shares of Journey Medical in a report released on Monday, November 4th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of $0.20 per shareNovember 6, 2024 | marketbeat.comFDA Approves New Option for RosaceaNovember 5, 2024 | msn.comUS FDA approves Journey Medical's drug for long-term skin conditionNovember 5, 2024 | msn.comWhat's Going On With Journey Medical Stock Today?November 5, 2024 | msn.comJourney Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaNovember 4, 2024 | globenewswire.comBiotech Stocks Facing FDA Decision In November 2024October 30, 2024 | markets.businessinsider.comJourney Medical Co. (NASDAQ:DERM) Short Interest UpdateJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 76,700 shares, a drop of 12.5% from the September 30th total of 87,700 shares. Approximately 0.8% of the company's stock are sold short. Based on an average daily volume of 62,700 shares, the days-to-cover ratio is presently 1.2 days.October 29, 2024 | marketbeat.comJourney Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology ConferenceOctober 25, 2024 | globenewswire.comJourney Medical Co. (NASDAQ:DERM) Short Interest Up 10.5% in SeptemberJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 87,700 shares, an increase of 10.5% from the September 15th total of 79,400 shares. Approximately 0.9% of the shares of the stock are sold short. Based on an average trading volume of 55,400 shares, the days-to-cover ratio is currently 1.6 days.October 15, 2024 | marketbeat.comShould you use biotin for thinning hair? Here’s what dermatologists sayOctober 12, 2024 | msn.comCase Study: Rare Subtype of Cutaneous Problem in a Breast Cancer PatientOctober 12, 2024 | msn.comJourney Medical (NASDAQ:DERM) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comJourney Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceOctober 3, 2024 | globenewswire.comMy Journey With HS, From Adolescence To AdulthoodOctober 1, 2024 | yahoo.comPVG Asset Management Corp Purchases New Holdings in Journey Medical Co. (NASDAQ:DERM)PVG Asset Management Corp acquired a new position in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 158,540 shares of the companOctober 1, 2024 | marketbeat.comMIGHTY 25: From PA to patient to advocate, Samantha Gomolka is a warriorSeptember 30, 2024 | yahoo.comObese Pit Bull Who Would ‘Eat While Lying Down’ Unbelievably Transformed After Weight Loss JourneySeptember 30, 2024 | msn.comWicklow volunteers to make 3,500-kilometre journey to donate vehicles to UkraineSeptember 30, 2024 | msn.comCan Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?September 28, 2024 | finance.yahoo.comReal Women on How They Worked Through Psoriasis & Psoriatic Arthritis in Their CareersSeptember 27, 2024 | msn.comWomen With This Scalp Condition May Be More Prone To Hair Loss. Here's How To Find ReliefSeptember 27, 2024 | yahoo.com10 Million People Suffer From This Scalp Condition. Here's How One Woman Found Relief.September 27, 2024 | msn.comJourney Medical Corp (DERM) Gets a Buy from Lake StreetSeptember 27, 2024 | markets.businessinsider.comNextech Launches Expanded Payments FunctionalitySeptember 25, 2024 | markets.businessinsider.comI Tried the Noninvasive Hair Loss Treatment Alma TED, and It Really WorkedSeptember 23, 2024 | msn.comSummit Health To Open In Former Crate & Barrel Store In BridgewaterSeptember 21, 2024 | msn.comSummit Health opens multispecialty facility in Fair Lawn, New JerseySeptember 20, 2024 | msn.comJourney Medical Co. (NASDAQ:DERM) Shares Sold by Acadian Asset Management LLCAcadian Asset Management LLC reduced its stake in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) by 57.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 94,404 shares of the companySeptember 19, 2024 | marketbeat.comJourney Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) ConferenceSeptember 9, 2024 | globenewswire.comJourney Medical (NASDAQ:DERM) Earns Buy Rating from Analysts at Lake Street CapitalLake Street Capital began coverage on shares of Journey Medical in a research report on Friday. They set a "buy" rating and a $9.00 price objective for the company.September 6, 2024 | marketbeat.comJourney Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comCambridge Investment Research Advisors Inc. Takes $1.66 Million Position in Journey Medical Co. (NASDAQ:DERM)Cambridge Investment Research Advisors Inc. purchased a new position in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 294,950 shares of the company's stock, vSeptember 4, 2024 | marketbeat.com4 lessons in the journey from PA to patientSeptember 1, 2024 | yahoo.comNew dermatologist joins Schlessinger MD in father-son collaborationAugust 25, 2024 | omaha.comRodman & Renshaw Initiates Coverage of Journey Medical (DERM) with Buy RecommendationAugust 23, 2024 | msn.comJourney Medical (NASDAQ:DERM) Receives New Coverage from Analysts at Rodman & RenshawRodman & Renshaw assumed coverage on Journey Medical in a research note on Thursday. They issued a "buy" rating and a $9.00 price objective on the stock.August 22, 2024 | marketbeat.comJourney Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsAugust 18, 2024 | finance.yahoo.comGet Longer, Stronger, and Thicker Hair With These Caffeine ShampoosAugust 16, 2024 | yahoo.comThe 12 Best Caffeine Shampoos for Thinning, Breaking, and Aging HairAugust 16, 2024 | msn.com Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now DERM Media Mentions By Week DERM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DERM News Sentiment▼1.930.60▲Average Medical News Sentiment DERM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DERM Articles This Week▼13▲DERM Articles Average Week Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Taysha Gene Therapies News Today Alumis News Today Akebia Therapeutics News Today Cryoport News Today Design Therapeutics News Today Procaps Group News Today biote News Today Neurogene News Today Voyager Therapeutics News Today Contineum Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DERM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DERM Stock Alerts